JP2017522357A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522357A5 JP2017522357A5 JP2017505480A JP2017505480A JP2017522357A5 JP 2017522357 A5 JP2017522357 A5 JP 2017522357A5 JP 2017505480 A JP2017505480 A JP 2017505480A JP 2017505480 A JP2017505480 A JP 2017505480A JP 2017522357 A5 JP2017522357 A5 JP 2017522357A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- preparing
- thf
- including methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 94
- 238000000034 method Methods 0.000 claims 37
- 238000004519 manufacturing process Methods 0.000 claims 20
- 239000000203 mixture Substances 0.000 claims 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 12
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 claims 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 9
- 239000012442 inert solvent Substances 0.000 claims 8
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 5
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims 5
- 230000003197 catalytic effect Effects 0.000 claims 5
- 238000005580 one pot reaction Methods 0.000 claims 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 4
- 238000010992 reflux Methods 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 238000003756 stirring Methods 0.000 claims 4
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 claims 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims 3
- 229960000583 acetic acid Drugs 0.000 claims 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 2
- 239000012362 glacial acetic acid Substances 0.000 claims 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims 1
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 150000004702 methyl esters Chemical class 0.000 claims 1
- 0 C*c1c(C=C(C(C)=O)C(OCCC#N)=O)ccc(C#N)c1 Chemical compound C*c1c(C=C(C(C)=O)C(OCCC#N)=O)ccc(C#N)c1 0.000 description 1
- RFJLQSVKIAMLCX-NTEUORMPSA-N CC(/C(/C(OCCC#N)=O)=C\c(ccc(C#N)c1)c1OC)=O Chemical compound CC(/C(/C(OCCC#N)=O)=C\c(ccc(C#N)c1)c1OC)=O RFJLQSVKIAMLCX-NTEUORMPSA-N 0.000 description 1
- WWAABAWXHRNWCT-UHFFFAOYSA-N CC(C(C(I)=O)C(OC)=C1)C=C1[Zn] Chemical compound CC(C(C(I)=O)C(OC)=C1)C=C1[Zn] WWAABAWXHRNWCT-UHFFFAOYSA-N 0.000 description 1
- SMWPNASNQIIBDW-UHFFFAOYSA-N CC(C1=C2C(c(ccc(N)c3)c3OC)C(C(OCCN)=O)=C(C)N1)=CNC2=O Chemical compound CC(C1=C2C(c(ccc(N)c3)c3OC)C(C(OCCN)=O)=C(C)N1)=CNC2=O SMWPNASNQIIBDW-UHFFFAOYSA-N 0.000 description 1
- WUPRJMHPZJWLHY-YYBBLCMGSA-N CCOc1ncc(C)c2c1[C@H](C(/C(/OC)=C\C(\C#N)=C/C)=C)C(C(N)=O)=C(C)N2 Chemical compound CCOc1ncc(C)c2c1[C@H](C(/C(/OC)=C\C(\C#N)=C/C)=C)C(C(N)=O)=C(C)N2 WUPRJMHPZJWLHY-YYBBLCMGSA-N 0.000 description 1
- ZXENVSJZOHXCKL-UHFFFAOYSA-N COc1c(C=O)ccc(C#N)c1 Chemical compound COc1c(C=O)ccc(C#N)c1 ZXENVSJZOHXCKL-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14179544.3 | 2014-08-01 | ||
| EP14179544 | 2014-08-01 | ||
| PCT/EP2015/067340 WO2016016287A1 (de) | 2014-08-01 | 2015-07-29 | Verfahren zur herstellung von (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carbox-amid und dessen aufreinigung für die verwendung als pharmazeutischer wirkstoff |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522357A JP2017522357A (ja) | 2017-08-10 |
| JP2017522357A5 true JP2017522357A5 (enExample) | 2018-09-06 |
| JP6818674B2 JP6818674B2 (ja) | 2021-01-20 |
Family
ID=51260727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017505480A Active JP6818674B2 (ja) | 2014-08-01 | 2015-07-29 | （４ｓ）−４−（４−シアノ−２−メトキシフェニル）−５−エトキシ−２，８−ジメチル−１，４−ジヒドロ−１，６−ナフチリジン−３−カルボキサミドを調製するための方法および医薬品有効成分としての使用のためのその精製 |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | USRE49575E1 (enExample) |
| EP (2) | EP3660015A1 (enExample) |
| JP (1) | JP6818674B2 (enExample) |
| KR (3) | KR102830206B1 (enExample) |
| CN (4) | CN106795155B (enExample) |
| AR (1) | AR101403A1 (enExample) |
| AU (1) | AU2015295376C1 (enExample) |
| BR (1) | BR112017001678B1 (enExample) |
| CA (2) | CA2956529A1 (enExample) |
| CL (1) | CL2017000263A1 (enExample) |
| CO (1) | CO2017000886A2 (enExample) |
| DK (1) | DK3174875T3 (enExample) |
| ES (1) | ES2828704T3 (enExample) |
| HR (1) | HRP20201800T1 (enExample) |
| HU (1) | HUE051350T2 (enExample) |
| IL (1) | IL250239B (enExample) |
| JO (1) | JO3648B1 (enExample) |
| LT (1) | LT3174875T (enExample) |
| MX (1) | MX369467B (enExample) |
| MY (1) | MY198066A (enExample) |
| PE (1) | PE20170141A1 (enExample) |
| PL (1) | PL3174875T3 (enExample) |
| PT (1) | PT3174875T (enExample) |
| RS (1) | RS60921B1 (enExample) |
| RU (1) | RU2729998C9 (enExample) |
| SG (1) | SG11201700785UA (enExample) |
| SI (1) | SI3174875T1 (enExample) |
| TW (1) | TWI684593B (enExample) |
| UA (1) | UA122773C2 (enExample) |
| UY (1) | UY36251A (enExample) |
| WO (1) | WO2016016287A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA122773C2 (uk) * | 2014-08-01 | 2021-01-06 | Байєр Фарма Акцієнгезелльшафт | Спосіб одержання (4s)-4-(4-ціано-2-метоксифеніл)-5-етокси-2,8-диметил-1,4-дигідро-1,6-нафтиридин-3-карбоксаміду і його очищення для застосування як фармацевтичного активного інгредієнта |
| PT3337800T (pt) * | 2015-08-21 | 2019-08-05 | Bayer Pharma AG | Método para a preparação de (4s)-4-(4-ciano-2-metoxi fenil)-5-etoxi-2,8-dimetil-1,4-di-hidro-1-6-naftiridina-3- carboxamida e purificação do mesmo para a utilização como ingrediente farmacêutico ativo |
| EP3560922A1 (de) | 2018-04-24 | 2019-10-30 | Bayer Aktiengesellschaft | Verfahren zur herstellung von (4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carbox-amid durch racemat-spaltung mittels diastereomerer weinsäureester |
| CA3132399A1 (en) | 2019-03-05 | 2020-09-10 | Bayer Aktiengesellschaft | Synthesis of 4-amino-5-methyl-1h-pyridin-2(1h)-on (intermediate compound for the synthesis of the mr antagonist finerenone) from 2-chloro-5-methyl-4-nitro-pyridine-1-oxide using the intermediate compound 2-chloro-5-methyl-4-pyridinamine |
| JP2022523984A (ja) | 2019-03-05 | 2022-04-27 | バイエル アクチェンゲゼルシャフト | ４－アミノ－５－メチルピリドンを調製する方法 |
| CR20220159A (es) * | 2019-10-17 | 2022-06-02 | Bayer Ag | Procedimiento para la preparación de (4s)–4–(4–ciano–2–metoxi–fenil)–5–hidroxi–2,8–dimetil–1,4–dihidro–1,6–naftiridin–3–carboxilato de 2–cianoetilo por separación de racematos por medio de éster de ácido tartárico diastereoisómero |
| EP4045501A1 (de) * | 2019-10-17 | 2022-08-24 | Bayer Aktiengesellschaft | Verfahren zur herstellung von 2-cyanoethyl (4s)-4-(4-cyano-2-methoxy-phenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylat durch racemat-spaltung mittels diastereomerer weinsäureester |
| MX2022004480A (es) * | 2019-10-17 | 2022-05-06 | Bayer Ag | Procedimiento para preparar esteres aciloximetilicos del acido (4s)-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6- naftiridin-3-carboxilico. |
| AU2020365351A1 (en) | 2019-10-17 | 2022-05-12 | Bayer Aktiengesellschaft | Photochemical process for producing (4R,4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamide |
| EP4138826A1 (en) | 2020-04-22 | 2023-03-01 | Bayer Aktiengesellschaft | Combination of finerenone and a sglt2 inhibitor for the treatment and/or prevention of cardiovascular and/or renal diseases |
| EP3900722A1 (en) | 2020-04-22 | 2021-10-27 | Bayer AG | Combination of finerenone and pecavaptan for the treatment and/or prevention of cardiovascular and/or renal diseases |
| WO2021254896A1 (en) | 2020-06-16 | 2021-12-23 | Bayer Aktiengesellschaft | Process for preparing (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide enabled by a catalytic asymmetric hantzsch ester reduction |
| CN112237573B (zh) * | 2020-10-29 | 2023-12-22 | 瑞阳制药股份有限公司 | 含finerenone的片剂及其制备方法 |
| WO2022214206A1 (en) | 2021-04-08 | 2022-10-13 | Bayer Aktiengesellschaft | Combination of finerenone and pecavaptan for the treatment and/or prevention of cardiovascular and/or renal diseases |
| CN114149427A (zh) * | 2021-12-18 | 2022-03-08 | 上海鼎雅药物化学科技有限公司 | 非奈利酮及其中间体的合成方法 |
| CN115340539B (zh) | 2022-01-19 | 2024-02-27 | 奥锐特药业股份有限公司 | 制备非奈利酮及其中间体的方法 |
| CN115340540A (zh) * | 2022-01-20 | 2022-11-15 | 奥锐特药业股份有限公司 | 制备非奈利酮及其中间体的方法 |
| CN114524812A (zh) * | 2022-03-18 | 2022-05-24 | 湖南凯铂生物药业有限公司 | 1,4-二氢-1,6-萘啶化合物的晶型制备以及合成方法 |
| EP4511365A1 (en) | 2022-04-18 | 2025-02-26 | Teva Pharmaceuticals International GmbH | Processes for the preparation of finerenone |
| EP4286368A1 (de) | 2022-05-31 | 2023-12-06 | Bayer Aktiengesellschaft | Verfahren zur herstellung von 4-formyl-3-methoxybenzonitril |
| WO2024075139A1 (en) * | 2022-10-06 | 2024-04-11 | Maithri Drugs Private Limited | A process for preparation of finerenone and intermediates thereof |
| JP2025537211A (ja) | 2022-11-04 | 2025-11-14 | ナンジン ブイケア ファーマテック カンパニー リミテッド | ジアステレオマー酒石酸エステルによりラセミ体を分割することによりフィネレノンを調製する方法 |
| AU2023385074A1 (en) * | 2022-11-23 | 2025-05-15 | Bayer Aktiengesellschaft | Treatment of chronic kidney disease in type i diabetes mellitus |
| IL321272A (en) | 2022-12-16 | 2025-08-01 | Bayer Ag | Continuous one-pot synthesis for the preparation of 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-8,2-dimethyl-4,1-dihydro-6,1-naphthyridine-3-carboxamide |
| WO2024147053A1 (en) * | 2023-01-03 | 2024-07-11 | Optimus Drugs Pvt Ltd | Improved process for the preparation of finerenone |
| TW202438065A (zh) * | 2023-03-17 | 2024-10-01 | 大陸商江蘇恒瑞醫藥股份有限公司 | 1,4-二氫-1,6-萘啶醯胺化合物的可藥用鹽、晶型及其製備方法 |
| WO2025104752A1 (en) * | 2023-11-18 | 2025-05-22 | Msn Laboratories Private Limited, R&D Center | Improved process for the preparation of (4s)4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide |
| CN120081840A (zh) * | 2023-12-01 | 2025-06-03 | 山东诚创蓝海医药科技有限公司 | 一种非奈利酮-马来酸共晶及其制备方法 |
| US20250313559A1 (en) | 2024-01-05 | 2025-10-09 | Bayer Aktiengesellschaft | Method of preventing or treating heart failure in a patient using (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide |
| WO2025247801A1 (en) * | 2024-05-30 | 2025-12-04 | Bayer Aktiengesellschaft | Determination of a dosage of a nonsteroidal mineralocorticoid receptor antagonist |
| CN119462643A (zh) * | 2024-10-17 | 2025-02-18 | 河北国龙制药有限公司 | 一种非奈利酮单晶及其制备方法和应用 |
| CN119019395A (zh) * | 2024-10-29 | 2024-11-26 | 成都诺和晟欣生物医药有限公司 | 一种非奈利酮晶型ⅰ的制备方法 |
| CN119684288A (zh) * | 2024-12-18 | 2025-03-25 | 安徽先和医药研究有限公司 | 非奈利酮的制备方法 |
| CN119684289A (zh) * | 2024-12-18 | 2025-03-25 | 安徽先和医药研究有限公司 | 一种非奈利酮的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL75987A (en) * | 1984-08-25 | 1991-07-18 | Goedecke Ag | Tri-and tetrasubstituted-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them |
| US4895860A (en) * | 1989-04-21 | 1990-01-23 | American Home Products Corporation | Novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides useful as anthihyperglycemic agents |
| DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
| DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
| GB9914825D0 (en) | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
| DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| DE19943639A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften |
| DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
| DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
| DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
| DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
| WO2006044775A2 (en) * | 2004-10-15 | 2006-04-27 | Bayer Pharmaceuticals Corporation | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| AU2005311930B9 (en) * | 2004-12-03 | 2009-09-10 | Merck Sharp & Dohme Corp. | Substituted piperazines as CB1 antagonists |
| AU2006201739A1 (en) * | 2005-05-05 | 2006-11-23 | The University Of North Carolina At Chapel Hill | Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles |
| US20080312209A1 (en) | 2005-07-12 | 2008-12-18 | Glaxo Group Limited | Piperazine Heteroaryl Derivatives as Gpr38 Agonists |
| DE102006026583A1 (de) | 2006-06-07 | 2007-12-13 | Bayer Healthcare Aktiengesellschaft | Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung |
| DE102006044696A1 (de) | 2006-09-22 | 2008-03-27 | Bayer Healthcare Ag | 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung |
| DE102007009494A1 (de) * | 2007-02-27 | 2008-08-28 | Bayer Healthcare Ag | Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung |
| CN102020587A (zh) | 2010-11-25 | 2011-04-20 | 大连凯飞精细化工有限公司 | 2-甲氧基-4-氰基苯甲醛的合成方法 |
| UA122773C2 (uk) * | 2014-08-01 | 2021-01-06 | Байєр Фарма Акцієнгезелльшафт | Спосіб одержання (4s)-4-(4-ціано-2-метоксифеніл)-5-етокси-2,8-диметил-1,4-дигідро-1,6-нафтиридин-3-карбоксаміду і його очищення для застосування як фармацевтичного активного інгредієнта |
-
2015
- 2015-07-29 UA UAA201701875A patent/UA122773C2/uk unknown
- 2015-07-29 WO PCT/EP2015/067340 patent/WO2016016287A1/de not_active Ceased
- 2015-07-29 AU AU2015295376A patent/AU2015295376C1/en active Active
- 2015-07-29 DK DK15742306.2T patent/DK3174875T3/da active
- 2015-07-29 KR KR1020237014295A patent/KR102830206B1/ko active Active
- 2015-07-29 CN CN201580053456.7A patent/CN106795155B/zh active Active
- 2015-07-29 HU HUE15742306A patent/HUE051350T2/hu unknown
- 2015-07-29 ES ES15742306T patent/ES2828704T3/es active Active
- 2015-07-29 SG SG11201700785UA patent/SG11201700785UA/en unknown
- 2015-07-29 RU RU2017106602A patent/RU2729998C9/ru active
- 2015-07-29 CA CA2956529A patent/CA2956529A1/en active Pending
- 2015-07-29 KR KR1020257022052A patent/KR20250108757A/ko active Pending
- 2015-07-29 CN CN202310620718.XA patent/CN116655630B/zh active Active
- 2015-07-29 LT LTEP15742306.2T patent/LT3174875T/lt unknown
- 2015-07-29 JP JP2017505480A patent/JP6818674B2/ja active Active
- 2015-07-29 MX MX2017001507A patent/MX369467B/es active IP Right Grant
- 2015-07-29 MY MYPI2017700334A patent/MY198066A/en unknown
- 2015-07-29 CN CN202310619597.7A patent/CN116655629A/zh active Pending
- 2015-07-29 PL PL15742306T patent/PL3174875T3/pl unknown
- 2015-07-29 SI SI201531406T patent/SI3174875T1/sl unknown
- 2015-07-29 US US17/002,115 patent/USRE49575E1/en active Active
- 2015-07-29 PT PT157423062T patent/PT3174875T/pt unknown
- 2015-07-29 PE PE2017000143A patent/PE20170141A1/es unknown
- 2015-07-29 CA CA3146285A patent/CA3146285C/en active Active
- 2015-07-29 CN CN202310616268.7A patent/CN116655627A/zh active Pending
- 2015-07-29 EP EP19213735.4A patent/EP3660015A1/de not_active Withdrawn
- 2015-07-29 US US15/329,043 patent/US10059707B2/en not_active Ceased
- 2015-07-29 KR KR1020177005278A patent/KR102527893B1/ko active Active
- 2015-07-29 HR HRP20201800TT patent/HRP20201800T1/hr unknown
- 2015-07-29 BR BR112017001678-8A patent/BR112017001678B1/pt active IP Right Grant
- 2015-07-29 RS RS20201213A patent/RS60921B1/sr unknown
- 2015-07-29 EP EP15742306.2A patent/EP3174875B1/de active Active
- 2015-07-30 JO JOP/2015/0184A patent/JO3648B1/ar active
- 2015-07-30 TW TW104124689A patent/TWI684593B/zh active
- 2015-07-31 UY UY0001036251A patent/UY36251A/es not_active Application Discontinuation
- 2015-07-31 AR ARP150102475A patent/AR101403A1/es unknown
-
2017
- 2017-01-23 IL IL250239A patent/IL250239B/en active IP Right Grant
- 2017-01-31 CO CONC2017/0000886A patent/CO2017000886A2/es unknown
- 2017-01-31 CL CL2017000263A patent/CL2017000263A1/es unknown
-
2018
- 2018-08-27 US US16/114,198 patent/US10399977B2/en not_active Ceased
-
2020
- 2020-11-03 US US17/087,659 patent/USRE49860E1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017522357A5 (enExample) | ||
| HRP20201800T1 (hr) | Postupak za pripravu (4s)-4-(4-cijano-2-metoksifenil)-5-etoksi-2,8-dimetil-1,4-dihidro-1-6-naftiridin-3-karboksamida i njegovo pročišćavanje za upotrebu kao aktivni farmaceutski sastojak | |
| RU2014120908A (ru) | Способ получения улипристала ацетата и его промежуточных продуктов | |
| JP2013533267A5 (enExample) | ||
| JP2012251113A5 (enExample) | ||
| JP2013523699A5 (enExample) | ||
| JP2014503001A5 (enExample) | ||
| PT2670751E (pt) | Métodos de fabrico de um composto profármaco inibidor da fixação do vih e intermediários | |
| JP2014511387A5 (enExample) | ||
| JP2016503812A5 (enExample) | ||
| CN117756801A (zh) | 一种非奈利酮的制备方法 | |
| KR101539761B1 (ko) | 물 또는 다양한 산을 첨가제로 이용한 새로운 마이클-첨가 반응을 통하여 화합물을 제조하는 방법 | |
| JP6251197B2 (ja) | 置換フェニルプロパノンを調製するためのプロセス | |
| JP6197868B2 (ja) | ピリダジノン化合物の製造方法 | |
| JP2004528380A (ja) | ゾルピデムの製造方法 | |
| TWI614256B (zh) | 合成四氫異喹啉噁唑烷的方法 | |
| JP6257115B2 (ja) | ３−アルキルチオ−２−ブロモピリジンの製造方法 | |
| CN103833717B (zh) | 一种奈必洛尔盐酸盐的合成方法 | |
| CN102153470B (zh) | 一种制备过酸酯化合物的方法 | |
| JP2012530834A5 (enExample) | ||
| CN103450092A (zh) | 一类甲硝唑-磺胺衍生物的合成及制备方法 | |
| JP5463051B2 (ja) | １，４―ジヒドロピリジン誘導体の製造法 | |
| CN102863341A (zh) | 一种（1r,2s）-2-芳基环丙胺衍生物的化学合成方法 | |
| CN114085173B (zh) | 一种2-硝基-4-甲砜基苯甲醛的制备方法 | |
| KR20160049217A (ko) | 블로난세린 중간체의 신규 제조방법 |